CONMED CORPORATION Selling, General and Administrative Expense
CONMED CORPORATION (CNMD) reported Selling, General and Administrative Expense of $145.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-29
- CONMED CORPORATION selling, general and administrative expense for the quarter ending 2026-06-30 was $145.55M, a 7.01% increase year-over-year.
- CONMED CORPORATION selling, general and administrative expense for the quarter ending 2025-12-31 was $166.76M, a 25.70% increase year-over-year.
- CONMED CORPORATION selling, general and administrative expense for the quarter ending 2025-09-30 was $140.34M, a 40.72% increase year-over-year.
- CONMED CORPORATION selling, general and administrative expense for the quarter ending 2025-06-30 was $136.02M, a 11.02% increase year-over-year.
- CONMED CORPORATION selling, general and administrative expense for fiscal 2025 was $591.97M, a 23.77% increase from fiscal 2024.
- CONMED CORPORATION selling, general and administrative expense for fiscal 2024 was $478.28M, a 4.92% decline from fiscal 2023.
- CONMED CORPORATION selling, general and administrative expense for fiscal 2023 was $503.04M, a 10.79% increase from fiscal 2022.
- CONMED CORPORATION selling, general and administrative expense for fiscal 2022 was $454.04M, a 9.47% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $145.55M 10-Q · filed 2026-07-29 | $287.25M 10-Q · filed 2026-07-29 | ||||||
| 2025-12-31 | $166.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $307.10M derived: sum of 2 quarters · filed 2026-02-17 | $443.12M derived: sum of 3 quarters · filed 2026-07-29 | $591.97M 10-K · filed 2026-02-17 | ||||
| 2025-09-30 | $140.34M 10-Q · filed 2025-11-06 | $276.36M derived: sum of 2 quarters · filed 2026-07-29 | $425.21M 10-Q · filed 2025-11-06 | $557.88M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $136.02M 10-Q · filed 2026-07-29 | $284.87M 10-Q · filed 2026-07-29 | $417.54M derived: sum of 3 quarters · filed 2026-07-29 | $517.27M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $148.85M 10-Q · filed 2025-05-01 | $281.52M derived: sum of 2 quarters · filed 2026-02-17 | $381.25M derived: sum of 3 quarters · filed 2026-02-17 | $503.77M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-12-31 | $132.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $232.40M derived: sum of 2 quarters · filed 2026-02-17 | $354.92M derived: sum of 3 quarters · filed 2026-02-17 | $478.28M 10-K · filed 2026-02-17 | ||||
| 2024-09-30 | $99.73M 10-Q · filed 2025-11-06 | $222.25M derived: sum of 2 quarters · filed 2025-11-06 | $345.61M 10-Q · filed 2025-11-06 | $463.57M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-06-30 | $122.52M 10-Q · filed 2025-07-31 | $245.88M 10-Q · filed 2025-07-31 | $363.84M derived: sum of 3 quarters · filed 2026-02-17 | $489.14M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-03-31 | $123.36M 10-Q · filed 2025-05-01 | $241.32M derived: sum of 2 quarters · filed 2026-02-17 | $366.61M derived: sum of 3 quarters · filed 2026-02-17 | $496.31M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2023-12-31 | $117.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $243.25M derived: sum of 2 quarters · filed 2026-02-17 | $372.95M derived: sum of 3 quarters · filed 2026-02-17 | $503.04M 10-K · filed 2026-02-17 | ||||
| 2023-09-30 | $125.30M 10-Q · filed 2024-10-31 | $255.00M derived: sum of 2 quarters · filed 2024-10-31 | $385.08M 10-Q · filed 2024-10-31 | $505.81M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-06-30 | $129.70M 10-Q · filed 2024-08-01 | $259.78M 10-Q · filed 2024-08-01 | $380.52M derived: sum of 3 quarters · filed 2025-02-18 | $495.12M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2023-03-31 | $130.08M 10-Q · filed 2024-04-25 | $250.82M derived: sum of 2 quarters · filed 2025-02-18 | $365.42M derived: sum of 3 quarters · filed 2025-02-18 | $481.25M derived: sum of 4 quarters · filed 2025-02-18 | ||||
| 2022-12-31 | $120.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $235.34M derived: sum of 2 quarters · filed 2025-02-18 | $351.16M derived: sum of 3 quarters · filed 2025-02-18 | $454.04M 10-K · filed 2025-02-18 | ||||
| 2022-09-30 | $114.60M 10-Q · filed 2023-10-26 | $230.43M derived: sum of 2 quarters · filed 2023-10-26 | $333.30M 10-Q · filed 2023-10-26 | $440.58M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $115.83M 10-Q · filed 2023-07-27 | $218.70M 10-Q · filed 2023-07-27 | $325.98M derived: sum of 3 quarters · filed 2024-02-28 | $430.71M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $102.88M 10-Q · filed 2023-04-27 | $210.15M derived: sum of 2 quarters · filed 2024-02-28 | $314.89M derived: sum of 3 quarters · filed 2024-02-28 | $419.29M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $107.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $212.01M derived: sum of 2 quarters · filed 2024-02-28 | $316.41M derived: sum of 3 quarters · filed 2024-02-28 | $414.75M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $104.74M 10-Q · filed 2022-10-27 | $209.13M derived: sum of 2 quarters · filed 2022-10-27 | $307.48M 10-Q · filed 2022-10-27 | $406.57M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | $104.40M 10-Q · filed 2022-07-28 | $202.74M 10-Q · filed 2022-07-28 | $301.83M derived: sum of 3 quarters · filed 2023-02-21 | $396.21M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | $98.34M 10-Q · filed 2022-05-05 | $197.44M derived: sum of 2 quarters · filed 2023-02-21 | $291.82M derived: sum of 3 quarters · filed 2023-02-21 | $376.29M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | $99.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $193.48M derived: sum of 2 quarters · filed 2023-02-21 | $277.95M derived: sum of 3 quarters · filed 2023-02-21 | $373.82M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | $94.38M 10-Q · filed 2021-10-28 | $178.85M derived: sum of 2 quarters · filed 2021-10-28 | $274.72M 10-Q · filed 2021-10-28 | $376.72M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | $84.47M 10-Q · filed 2021-07-29 | $180.34M 10-Q · filed 2021-07-29 | $282.34M derived: sum of 3 quarters · filed 2022-02-22 | $380.53M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | $95.87M 10-Q · filed 2021-04-29 | $197.87M derived: sum of 2 quarters · filed 2022-02-22 | $296.06M derived: sum of 3 quarters · filed 2022-02-22 | $396.78M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | $102.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $200.19M derived: sum of 2 quarters · filed 2022-02-22 | $300.91M derived: sum of 3 quarters · filed 2022-02-22 | $400.14M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | $98.19M 10-Q · filed 2020-10-29 | $198.91M derived: sum of 2 quarters · filed 2020-10-29 | $298.14M 10-Q · filed 2020-10-29 | $394.60M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-06-30 | $100.73M 10-Q · filed 2020-07-30 | $199.95M 10-Q · filed 2020-07-30 | $296.41M derived: sum of 3 quarters · filed 2021-02-22 | $381.40M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2019-03-31 | $99.23M 10-Q · filed 2020-04-30 | $195.69M derived: sum of 2 quarters · filed 2021-02-22 | $280.67M derived: sum of 3 quarters · filed 2021-02-22 | $370.27M derived: sum of 4 quarters · filed 2021-02-22 | ||||
| 2018-12-31 | $96.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $181.44M derived: sum of 2 quarters · filed 2021-02-22 | $271.05M derived: sum of 3 quarters · filed 2021-02-22 | $355.62M 10-K · filed 2021-02-22 | ||||
| 2018-09-30 | $84.98M 10-Q · filed 2019-10-31 | $174.59M derived: sum of 2 quarters · filed 2019-10-31 | $259.16M 10-Q · filed 2019-10-31 | $351.56M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $89.60M 10-Q · filed 2019-08-01 | $174.17M 10-Q · filed 2019-08-01 | $266.57M derived: sum of 3 quarters · filed 2020-02-24 | $347.38M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $84.57M 10-Q · filed 2019-04-26 | $176.97M derived: sum of 2 quarters · filed 2020-02-24 | $257.78M derived: sum of 3 quarters · filed 2020-02-24 | $341.61M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $92.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $173.21M derived: sum of 2 quarters · filed 2020-02-24 | $257.04M derived: sum of 3 quarters · filed 2020-02-24 | $351.80M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $80.81M 10-Q · filed 2018-11-02 | $164.63M derived: sum of 2 quarters · filed 2018-11-02 | $259.40M 10-Q · filed 2018-11-02 | $346.12M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $83.83M 10-Q · filed 2018-08-02 | $178.59M 10-Q · filed 2018-08-02 | $265.31M derived: sum of 3 quarters · filed 2019-02-25 | $344.32M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $94.76M 10-Q · filed 2018-04-26 | $181.48M derived: sum of 2 quarters · filed 2019-02-25 | $260.49M derived: sum of 3 quarters · filed 2019-02-25 | $347.22M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $86.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $165.73M derived: sum of 2 quarters · filed 2019-02-25 | $252.46M derived: sum of 3 quarters · filed 2019-02-25 | $338.40M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $79.01M 10-Q · filed 2017-11-02 | $165.74M derived: sum of 2 quarters · filed 2017-11-02 | $251.68M 10-Q · filed 2017-11-02 | $334.35M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $86.73M 10-Q · filed 2017-07-27 | $172.67M 10-Q · filed 2017-07-27 | $255.34M derived: sum of 3 quarters · filed 2018-02-26 | $327.40M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $85.94M 10-Q · filed 2017-04-27 | $168.61M derived: sum of 2 quarters · filed 2018-02-26 | $240.67M derived: sum of 3 quarters · filed 2018-02-26 | $314.25M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $82.67M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $154.72M derived: sum of 2 quarters · filed 2018-02-26 | $228.31M derived: sum of 3 quarters · filed 2018-02-26 | $303.09M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $72.06M 10-Q · filed 2016-10-28 | $145.64M derived: sum of 2 quarters · filed 2016-10-28 | $220.42M 10-Q · filed 2016-10-28 | $300.26M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $73.58M 10-Q · filed 2016-07-28 | $148.37M 10-Q · filed 2016-07-28 | $228.21M derived: sum of 3 quarters · filed 2017-02-27 | $315.26M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $74.79M 10-Q · filed 2016-05-02 | $154.63M derived: sum of 2 quarters · filed 2017-02-27 | $241.68M derived: sum of 3 quarters · filed 2017-02-27 | $319.91M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $79.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $166.89M derived: sum of 2 quarters · filed 2017-02-27 | $245.13M derived: sum of 3 quarters · filed 2017-02-27 | $323.49M 10-K · filed 2017-02-27 | $293.94M 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $87.06M 10-Q · filed 2015-10-23 | $71.24M 10-Q · filed 2014-10-24 | $165.29M derived: sum of 2 quarters · filed 2015-10-23 | $243.65M 10-Q · filed 2015-10-23 | $219.08M 10-Q · filed 2014-10-24 | $345.36M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $78.23M 10-Q · filed 2015-07-27 | $74.03M 10-Q · filed 2014-07-25 | $156.60M 10-Q · filed 2015-07-27 | $147.84M 10-Q · filed 2014-07-25 | $258.30M derived: sum of 3 quarters · filed 2016-02-23 | $331.78M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $78.36M 10-Q · filed 2015-04-24 | $73.82M 10-Q · filed 2014-04-25 | $180.07M derived: sum of 2 quarters · filed 2016-02-23 | $253.54M derived: sum of 3 quarters · filed 2016-02-23 | $330.72M derived: sum of 4 quarters · filed 2016-02-23 | |||
| 2013-12-31 | $101.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $175.18M derived: sum of 2 quarters · filed 2016-02-23 | $252.35M derived: sum of 3 quarters · filed 2016-02-23 | $330.08M 10-K · filed 2016-02-23 | $310.73M 10-K · filed 2014-02-24 | |||
| 2013-09-30 | $73.48M 10-Q · filed 2014-10-24 | $150.65M derived: sum of 2 quarters · filed 2014-10-24 | $228.38M 10-Q · filed 2014-10-24 | $308.27M derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-06-30 | $77.17M 10-Q · filed 2014-07-25 | $154.90M 10-Q · filed 2014-07-25 | $234.79M derived: sum of 3 quarters · filed 2015-02-23 | $308.86M derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2013-03-31 | $77.72M 10-Q · filed 2014-04-25 | $157.62M derived: sum of 2 quarters · filed 2015-02-23 | $231.68M derived: sum of 3 quarters · filed 2015-02-23 | $305.39M derived: sum of 4 quarters · filed 2015-02-23 | ||||
| 2012-12-31 | $79.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $153.96M derived: sum of 2 quarters · filed 2015-02-23 | $227.66M derived: sum of 3 quarters · filed 2015-02-23 | $302.47M 10-K · filed 2015-02-23 | ||||
| 2012-09-30 | $74.06M 10-Q · filed 2013-10-28 | $147.77M derived: sum of 2 quarters · filed 2013-10-28 | $222.58M 10-Q · filed 2013-10-28 | $292.90M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-06-30 | $73.71M 10-Q · filed 2013-07-29 | $148.51M 10-Q · filed 2013-07-29 | $218.84M derived: sum of 3 quarters · filed 2014-02-24 | $287.19M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-03-31 | $74.81M 10-Q · filed 2013-04-29 | $145.13M derived: sum of 2 quarters · filed 2014-02-24 | $213.48M derived: sum of 3 quarters · filed 2014-02-24 | $281.34M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2011-12-31 | $70.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $138.68M derived: sum of 2 quarters · filed 2014-02-24 | $206.54M derived: sum of 3 quarters · filed 2014-02-24 | $276.62M 10-K · filed 2014-02-24 | ||||
| 2011-09-30 | $68.35M 10-Q · filed 2012-10-29 | $136.21M derived: sum of 2 quarters · filed 2012-10-29 | $206.29M 10-Q · filed 2012-10-29 | $274.62M derived: sum of 4 quarters · filed 2013-02-25 | ||||
| 2011-06-30 | $67.86M 10-Q · filed 2012-07-30 | $137.94M 10-Q · filed 2012-07-30 | $206.27M derived: sum of 3 quarters · filed 2013-02-25 | $272.36M derived: sum of 4 quarters · filed 2013-02-25 | ||||
| 2011-03-31 | $70.08M 10-Q · filed 2012-05-01 | $138.40M derived: sum of 2 quarters · filed 2013-02-25 | $204.50M derived: sum of 3 quarters · filed 2013-02-25 | $275.99M derived: sum of 4 quarters · filed 2013-02-25 | ||||
| 2010-12-31 | $68.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $134.42M derived: sum of 2 quarters · filed 2013-02-25 | $205.91M derived: sum of 3 quarters · filed 2013-02-25 | $276.46M 10-K · filed 2013-02-25 | ||||
| 2010-09-30 | $66.09M 10-Q · filed 2011-11-01 | $137.59M derived: sum of 2 quarters · filed 2011-11-01 | $208.14M 10-Q · filed 2011-11-01 | |||||
| 2010-06-30 | $71.49M 10-Q · filed 2011-08-09 | $142.05M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $266.31M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |